38012622|t|Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese woman: a three-center case-control study.
38012622|a|OBJECTIVE: To investigate the potential correlation between piwi-like RNA-mediated gene silencing 1 (PIWIL1) polymorphisms and susceptibility to epithelial ovarian cancer (EOC). METHODS: A case-control study was conducted to evaluate the susceptibility of EOC using multinomial logistic regression analysis. The study analyzed the relationship between five functional single nucleotide polymorphisms (SNPs) in the PIWIL1 gene and EOC risk. Genotyping of 288 cases and 361 healthy samples from South China was identified using a TaqMan assay. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to estimate the relationship between the five selected SNPs and EOC susceptibility. RESULTS: Among the five SNPs analyzed, the rs10848087 G > A and rs7957349 G > C variants significantly increased the susceptibility of EOC, rs10773771 C > T was associated with a decreased risk of EOC, while the rs35997018 and rs1106042 variants were not in Hardy-Weinberg equilibrium (p < 0.05). The rs10848087 G > A was significantly associated with increased risk of EOC in individuals with metastasis, FIGO stage I and III, low and high pathological grade, tumor numbers <= 3 and > 3, tumor size > 3 cm and <= 3 cm, pregnant more than 3 times, pre-menopausal status, and strong positive expression of ER (estrogen receptor), PR (progesterone receptor), PAX8 (paired-box 8), wild-type p53 (tumor protein 53), WT1 (Wilm's tumor gene), P16 (cyclin-dependent kinase inhibitor 2A). In addition, rs10848087 G > A enhanced the EOC risk of cases with negative/mild positive expression of wild p53 and Ki67, and with or without mutant p53 expression. The rs7957349 G > C variant was linked to an increased risk of EOC in subgroups with certain characteristics, including age equal or less than 53 years, metastasis, clinical stage I, low pathological grade, tumor number, tumor size, pregnant times, post-menopause, pre-menopause, and strong positive expression of wild p53 and Ki67 (Antigen identified by monoclonal antibody Ki-67), as well as without mutant p53 expression. The rs10773771 CT/TT alleles were identified to have a protective effect on EOC in women aged 53 years or older, as well as in cases with metastasis, advanced clinical stage, high pathological grade, multiple tumors, tumor size equal to or less than 3 cm, history of pregnancy, post-menopausal status, and strong positive expression of ER, PR, wild-type p53, PAX8, WT1, P16, and Ki67. Furthermore, rs10773771 CT/TT also showed a protective effect in patients with negative or mildly positive expression of PR, PAX8, wild-type p53, WT1, and P16, as well as positive expression of mutant p53. Compared to the reference haplotype GCG, individuals harboring haplotypes GTG were found to have a significantly decreased susceptibility to EOC. PIWIL1 was significantly expressed in the thyroid, pituitary, and adrenal glands with rs7957349 CC alleles. CONCLUSIONS: PIWIL1 rs10848087 and rs7957349 were associated with increased risk of EOC, while rs10773771 may have a protective effect against EOC. These genetic variants may serve as potential biomarkers for EOC susceptibility in the South China population.
38012622	21	27	PIWIL1	Gene	9271
38012622	51	76	epithelial ovarian cancer	Disease	MESH:D000077216
38012622	217	256	piwi-like RNA-mediated gene silencing 1	Gene	9271
38012622	258	264	PIWIL1	Gene	9271
38012622	302	327	epithelial ovarian cancer	Disease	MESH:D000077216
38012622	329	332	EOC	Disease	MESH:D000077216
38012622	413	416	EOC	Disease	MESH:D000077216
38012622	571	577	PIWIL1	Gene	9271
38012622	587	590	EOC	Disease	MESH:D000077216
38012622	832	835	EOC	Disease	MESH:D000077216
38012622	895	905	rs10848087	SNP	tmVar:rs10848087;VariantGroup:1;CorrespondingGene:9271;RS#:10848087;CorrespondingSpecies:9606
38012622	906	911	G > A	DNAMutation	tmVar:c|SUB|G||A;VariantGroup:5;CorrespondingGene:7157;CorrespondingSpecies:9606
38012622	916	925	rs7957349	SNP	tmVar:rs7957349;VariantGroup:3;CorrespondingGene:9271;RS#:7957349;CorrespondingSpecies:9606
38012622	926	931	G > C	DNAMutation	tmVar:c|SUB|G||C;VariantGroup:6;CorrespondingGene:7157;CorrespondingSpecies:9606
38012622	987	990	EOC	Disease	MESH:D000077216
38012622	992	1002	rs10773771	SNP	tmVar:rs10773771;VariantGroup:2;CorrespondingGene:9271;RS#:10773771;CorrespondingSpecies:9606
38012622	1003	1008	C > T	DNAMutation	tmVar:c|SUB|C||T;VariantGroup:7;CorrespondingGene:2099;CorrespondingSpecies:9606
38012622	1049	1052	EOC	Disease	MESH:D000077216
38012622	1064	1074	rs35997018	SNP	tmVar:rs35997018;VariantGroup:0;CorrespondingGene:9271;RS#:35997018;CorrespondingSpecies:9606
38012622	1079	1088	rs1106042	SNP	tmVar:rs1106042;VariantGroup:4;CorrespondingGene:9271;RS#:1106042;CorrespondingSpecies:9606
38012622	1153	1163	rs10848087	SNP	tmVar:rs10848087;VariantGroup:1;CorrespondingGene:9271;RS#:10848087;CorrespondingSpecies:9606
38012622	1164	1169	G > A	DNAMutation	tmVar:c|SUB|G||A;VariantGroup:5;CorrespondingGene:7157;CorrespondingSpecies:9606
38012622	1222	1225	EOC	Disease	MESH:D000077216
38012622	1246	1256	metastasis	Disease	MESH:D009362
38012622	1313	1318	tumor	Disease	MESH:D009369
38012622	1341	1346	tumor	Disease	MESH:D009369
38012622	1457	1459	ER	Gene	2099
38012622	1461	1478	estrogen receptor	Gene	2099
38012622	1481	1483	PR	Gene	5241
38012622	1485	1506	progesterone receptor	Gene	5241
38012622	1509	1513	PAX8	Gene	7849
38012622	1515	1527	paired-box 8	Gene	7849
38012622	1540	1543	p53	Gene	7157
38012622	1545	1561	tumor protein 53	Gene	7157
38012622	1564	1567	WT1	Gene	7490
38012622	1589	1592	P16	Gene	1029
38012622	1594	1630	cyclin-dependent kinase inhibitor 2A	Gene	1029
38012622	1646	1656	rs10848087	SNP	tmVar:rs10848087;VariantGroup:1;CorrespondingGene:9271;RS#:10848087;CorrespondingSpecies:9606
38012622	1657	1662	G > A	DNAMutation	tmVar:c|SUB|G||A;VariantGroup:5;CorrespondingGene:7157;CorrespondingSpecies:9606
38012622	1676	1679	EOC	Disease	MESH:D000077216
38012622	1741	1744	p53	Gene	7157
38012622	1782	1785	p53	Gene	7157
38012622	1802	1811	rs7957349	SNP	tmVar:rs7957349;VariantGroup:3;CorrespondingGene:9271;RS#:7957349;CorrespondingSpecies:9606
38012622	1812	1817	G > C	DNAMutation	tmVar:c|SUB|G||C;VariantGroup:6;CorrespondingGene:7157;CorrespondingSpecies:9606
38012622	1861	1864	EOC	Disease	MESH:D000077216
38012622	1951	1961	metastasis	Disease	MESH:D009362
38012622	2005	2010	tumor	Disease	MESH:D009369
38012622	2019	2024	tumor	Disease	MESH:D009369
38012622	2117	2120	p53	Gene	7157
38012622	2207	2210	p53	Gene	7157
38012622	2227	2237	rs10773771	SNP	tmVar:rs10773771;VariantGroup:2;CorrespondingGene:9271;RS#:10773771;CorrespondingSpecies:9606
38012622	2299	2302	EOC	Disease	MESH:D000077216
38012622	2361	2371	metastasis	Disease	MESH:D009362
38012622	2432	2438	tumors	Disease	MESH:D009369
38012622	2440	2445	tumor	Disease	MESH:D009369
38012622	2559	2561	ER	Gene	2099
38012622	2563	2565	PR	Gene	5241
38012622	2577	2580	p53	Gene	7157
38012622	2582	2586	PAX8	Gene	7849
38012622	2588	2591	WT1	Gene	7490
38012622	2593	2596	P16	Gene	1029
38012622	2621	2631	rs10773771	SNP	tmVar:rs10773771;VariantGroup:2;CorrespondingGene:9271;RS#:10773771;CorrespondingSpecies:9606
38012622	2729	2731	PR	Gene	5241
38012622	2733	2737	PAX8	Gene	7849
38012622	2749	2752	p53	Gene	7157
38012622	2754	2757	WT1	Gene	7490
38012622	2763	2766	P16	Gene	1029
38012622	2809	2812	p53	Gene	7157
38012622	2955	2958	EOC	Disease	MESH:D000077216
38012622	2960	2966	PIWIL1	Gene	9271
38012622	3046	3055	rs7957349	SNP	tmVar:rs7957349;VariantGroup:3;CorrespondingGene:9271;RS#:7957349;CorrespondingSpecies:9606
38012622	3081	3087	PIWIL1	Gene	9271
38012622	3088	3098	rs10848087	SNP	tmVar:rs10848087;VariantGroup:1;CorrespondingGene:9271;RS#:10848087;CorrespondingSpecies:9606
38012622	3103	3112	rs7957349	SNP	tmVar:rs7957349;VariantGroup:3;CorrespondingGene:9271;RS#:7957349;CorrespondingSpecies:9606
38012622	3152	3155	EOC	Disease	MESH:D000077216
38012622	3163	3173	rs10773771	SNP	tmVar:rs10773771;VariantGroup:2;CorrespondingGene:9271;RS#:10773771;CorrespondingSpecies:9606
38012622	3211	3214	EOC	Disease	MESH:D000077216
38012622	3277	3280	EOC	Disease	MESH:D000077216
38012622	Association	MESH:D000077216	5241
38012622	Positive_Correlation	MESH:D000077216	RS#:10848087;CorrespondingGene:9271
38012622	Association	2099	9271
38012622	Negative_Correlation	CorrespondingGene:2099;CorrespondingSpecies:9606;VariantGroup:7;tmVar:c	MESH:D000077216
38012622	Negative_Correlation	MESH:D000077216	RS#:10773771;CorrespondingGene:9271
38012622	Association	MESH:D009362	RS#:10848087;CorrespondingGene:9271
38012622	Positive_Correlation	CorrespondingGene:7157;CorrespondingSpecies:9606;VariantGroup:5;tmVar:c	MESH:D000077216
38012622	Positive_Correlation	CorrespondingGene:7157;CorrespondingSpecies:9606;VariantGroup:6;tmVar:c	MESH:D000077216
38012622	Association	MESH:D000077216	7490
38012622	Association	CorrespondingGene:7157;CorrespondingSpecies:9606;VariantGroup:5;tmVar:c	MESH:D009369
38012622	Association	MESH:D009369	RS#:10848087;CorrespondingGene:9271
38012622	Association	MESH:D000077216	7849
38012622	Association	MESH:D000077216	2099
38012622	Association	7490	9271
38012622	Association	MESH:D000077216	1029
38012622	Association	MESH:D000077216	9271
38012622	Association	5241	9271
38012622	Association	MESH:D009369	RS#:7957349;CorrespondingGene:9271
38012622	Positive_Correlation	MESH:D000077216	RS#:7957349;CorrespondingGene:9271
38012622	Association	MESH:D009362	RS#:7957349;CorrespondingGene:9271
38012622	Association	1029	9271
38012622	Association	MESH:D000077216	7157
38012622	Association	7849	9271
38012622	Association	MESH:D009362	9271
38012622	Association	MESH:D009369	7157
38012622	Association	MESH:D009369	9271

